It has been established that miR-543-3p directly regulated GLT-1 mRNA (SLC1A2 gene), and the inhibition of miR-543-3p upregulated GLT-1 protein expression and function, alleviating dyskinesia in PD models (Wu et al., 2019). This evidence concerns the gene SLC1A2 and Parkinson disease.